The Latest Breaking News from Obesity

Mexicans, who consume on average 166 litres of fizzy drinks a year, will face a near doubling of the tax rate

There already exists a cure for ennui, and it’s found in the pub. But when former BBC producer and Canadian radio presenter Michael Finnerty — famous enough over there to have his face on billboards — finds his life without lustre, he does not turn to booze, which shows a…

Caesareans drive rise in assisted deliveries as experts warn of complex pregnancies linked to age, obesity and other conditions

For the first time, more school-aged children are obese than underweight around the world, with the exception of sub-Saharan Africa and South Asia. The warning came in a report released on Wednesday by the United Nations children’s agency Unicef.

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative clinical effectiveness and value of Novo Nordisk A/S’ (NYSE:NVO) semaglutide (Wegovy) and Eli Lilly and Co.’s (NYSE:LLY) tirzepatide (Zepbound) for obesity management.

The pharmaceutical giant will axe over 11% of its global workforce as rival Eli Lilly gathers market share in the obesity drug market.

About one in 10 children globally is obese, the UN agency said.

Major study by Unicef finds 391 million children across the globe now overweight or obese

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications

Cheap ultra-processed food behind rise in overweight children, with one in 10 now obese globally, says Unicef

3 biotech stocks under $5 with cancer, obesity, and psychedelic therapies offer speculative investors high-risk, high-reward potential: HOTH, SILO, and ANIX.